BioTelemetry (BEAT) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
BioTelemetry, Inc. Reports Fourth Quarter 2019 Financial Results
February 26, 2020 4:05 PM ESTAnnounces Record Quarterly and Full Year Results
MALVERN, Pa., Feb. 26, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter and year ended December 31, 2019.
Quarter Highlights
Recognized quarterly revenue of $112.0 millionReached 8.1% year-over-year quarterly revenue growthAchieved 30th consecutive quarter of year-over-year revenue growthReported GAAP net income of $1.6 million, or 1.4% of revenueRealized... More
